KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Deferred Taxes (2016 - 2025)

Petmed Express' Deferred Taxes history spans 16 years, with the latest figure at $5.5 million for Q1 2025.

  • For Q1 2025, Deferred Taxes rose 652.75% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $5.5 million, up 1002.62%, while the annual FY2025 figure was $5.2 million, 1697.6% up from the prior year.
  • Deferred Taxes reached $5.5 million in Q1 2025 per PETS's latest filing, up from $465000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $5.5 million in Q1 2025 to a low of -$1.6 million in Q1 2021.
  • Average Deferred Taxes over 5 years is $84647.1, with a median of -$299000.0 recorded in 2022.
  • Peak YoY movement for Deferred Taxes: plummeted 1069.78% in 2021, then surged 1333.33% in 2023.
  • A 5-year view of Deferred Taxes shows it stood at -$484000.0 in 2021, then skyrocketed by 38.22% to -$299000.0 in 2022, then grew by 3.01% to -$290000.0 in 2023, then skyrocketed by 260.34% to $465000.0 in 2024, then soared by 1078.49% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Deferred Taxes are $5.5 million (Q1 2025), $465000.0 (Q4 2024), and -$670000.0 (Q3 2024).